应激激活蛋白激酶通路作为开发新抗真菌药物的潜在目标
Rebeca Alonso-Monge1, José Pedro Guirao-Abad2, Juan Carlos Argüelles3
1Unidad de Microbiología, Departamento de Microbiología y Parasitología, Facultad de Farmacia, Universidad Complutense de Madrid, Plaza de Ramón y Cajal s/n, E-28040 Madrid, Spain.
Journal of fungi (Basel, Switzerland)
|February 26, 2026
概括
开发新的抗真菌疗法至关重要,因为真菌感染构成全球风险. 针对人类缺少的压力激活蛋白激酶 (SAPK) 途径,为开发新型抗真菌药物提供了一个有前途的战略.
科学领域:
- 菌类学 菌类学是指菌类学.
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 真菌感染是全球健康的重大威胁,需要新的治疗策略.
- 有限的抗真菌药物选择和真菌的真核性质使选择性药物标的识别变得复杂.
- 应激激活蛋白激酶 (SAPK) 途径对于真菌的适应和毒性至关重要,为新的抗真菌药物提供潜在的点.
研究的目的:
- 探索SAPK途径,特别是两组系统的作用,作为新抗真菌疗法的潜在标.
- 审查世卫组织优先的真菌病原体中SAPK途径和抗真菌信号之间的联系.
- 突出调制SAPK信号传导的潜力,以开发新型抗真菌药物.
主要方法:
- 文献综述,重点关注真菌信号和耐药性中的SAPK通路.
- 对SAPK通路参与毒性和对抗真菌药物的反应的分析.
- 检查两个组件系统作为SAPK路径调制的潜在目标.
主要成果:
- SAPK通路对于真菌的生存,适应和毒性至关重要.
- 这些通路在真菌对环境压力和某些抗真菌剂的反应期间被激活.
- 这种由两部分组成的系统是真菌特有的,它为准SAPK信号提供了一个潜在的机制.
结论:
- 调节SAPK信号,可能通过准两组系统,是开发新抗真菌疗法的可行策略.
- 将SAPK调节剂与现有的抗真菌药物结合起来,可能会提高治疗效率.
- 在优先的真菌病原体中对SAPK通路的进一步研究,如*Cryptococcus neoformans*,*Candida auris*,*Aspergillus fumigatus*和*Candida albicans*是有必要的.
相关概念视频
01:07MAPK Signaling Cascades
8.8K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.8K
01:25cAMP-dependent Protein Kinase Pathways
8.7K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.7K
01:22PI3K/mTOR/AKT Signaling Pathway
5.8K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.8K
01:19Interactions Between Signaling Pathways
7.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.4K
01:20The JAK-STAT Signaling Pathway
13.4K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.4K
03:03mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K